RAMSAY GENERALE DE SANTE SA (GDS.PA) Fundamental Analysis & Valuation

EPA:GDS • FR0000044471

Current stock price

10.3 EUR
0 (0%)
Last:

This GDS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. GDS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year GDS has reported negative net income.
  • In the past year GDS had a positive cash flow from operations.
  • In multiple years GDS reported negative net income over the last 5 years.
  • In the past 5 years GDS always reported a positive cash flow from operatings.
GDS.PA Yearly Net Income VS EBIT VS OCF VS FCFGDS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.82%, GDS is doing worse than 82.76% of the companies in the same industry.
  • GDS has a worse Return On Equity (-4.75%) than 82.76% of its industry peers.
  • The Return On Invested Capital of GDS (2.29%) is worse than 75.86% of its industry peers.
  • GDS had an Average Return On Invested Capital over the past 3 years of 1.77%. This is below the industry average of 6.20%.
  • The 3 year average ROIC (1.77%) for GDS is below the current ROIC(2.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.82%
ROE -4.75%
ROIC 2.29%
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.77%
ROIC(5y)1.41%
GDS.PA Yearly ROA, ROE, ROICGDS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Operating Margin of GDS (3.08%) is worse than 62.07% of its industry peers.
  • GDS's Operating Margin has improved in the last couple of years.
  • GDS has a better Gross Margin (77.91%) than 75.86% of its industry peers.
  • In the last couple of years the Gross Margin of GDS has remained more or less at the same level.
Industry RankSector Rank
OM 3.08%
PM (TTM) N/A
GM 77.91%
OM growth 3Y23.45%
OM growth 5Y19.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
GDS.PA Yearly Profit, Operating, Gross MarginsGDS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. GDS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDS is destroying value.
  • GDS has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GDS remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, GDS has a worse debt to assets ratio.
GDS.PA Yearly Shares OutstandingGDS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GDS.PA Yearly Total Debt VS Total AssetsGDS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.04, we must say that GDS is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.04, GDS is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of GDS is 7.93, which is on the high side as it means it would take GDS, 7.93 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of GDS (7.93) is better than 62.07% of its industry peers.
  • A Debt/Equity ratio of 3.27 is on the high side and indicates that GDS has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 3.27, GDS is doing worse than 79.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.27
Debt/FCF 7.93
Altman-Z 1.04
ROIC/WACC0.47
WACC4.83%
GDS.PA Yearly LT Debt VS Equity VS FCFGDS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.77 indicates that GDS may have some problems paying its short term obligations.
  • GDS has a Current ratio (0.77) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.68 indicates that GDS may have some problems paying its short term obligations.
  • GDS has a Quick ratio of 0.68. This is comparable to the rest of the industry: GDS outperforms 51.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.68
GDS.PA Yearly Current Assets VS Current LiabilitesGDS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GDS.PA Growth Analysis

3.1 Past

  • GDS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.37%.
  • Looking at the last year, GDS shows a small growth in Revenue. The Revenue has grown by 4.70% in the last year.
  • GDS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.95% yearly.
EPS 1Y (TTM)-0.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.05%
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%3.27%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GDS.PA Yearly Revenue VS EstimatesGDS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

Find the best growth stocksShow best growing peers

2

4. GDS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GDS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GDS.PA Price Earnings VS Forward Price EarningsGDS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • GDS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, GDS is valued cheaper than 96.55% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.23
EV/EBITDA 8.33
GDS.PA Per share dataGDS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GDS.PA Dividend Analysis

5.1 Amount

  • GDS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GDS.PA Fundamentals: All Metrics, Ratios and Statistics

RAMSAY GENERALE DE SANTE SA

EPA:GDS (4/10/2026, 7:00:00 PM)

10.3

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)N/A
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners6.67%
Ins Owner ChangeN/A
Market Cap1.14B
Revenue(TTM)5.24B
Net Income(TTM)-54.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF 2.23
P/OCF 1.76
P/B 1
P/tB N/A
EV/EBITDA 8.33
EPS(TTM)-0.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.62
FCFY44.85%
OCF(TTM)5.86
OCFY56.85%
SpS47.49
BVpS10.31
TBVpS-10.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.82%
ROE -4.75%
ROCE 3.12%
ROIC 2.29%
ROICexc 2.39%
ROICexgc 4.48%
OM 3.08%
PM (TTM) N/A
GM 77.91%
FCFM 9.73%
ROA(3y)-0.29%
ROA(5y)0.37%
ROE(3y)-1.76%
ROE(5y)2.11%
ROIC(3y)1.77%
ROIC(5y)1.41%
ROICexc(3y)1.91%
ROICexc(5y)1.51%
ROICexgc(3y)3.58%
ROICexgc(5y)2.81%
ROCE(3y)2.41%
ROCE(5y)1.91%
ROICexgc growth 3Y36.97%
ROICexgc growth 5Y27.82%
ROICexc growth 3Y34.74%
ROICexc growth 5Y25.95%
OM growth 3Y23.45%
OM growth 5Y19.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y-0.65%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 3.27
Debt/FCF 7.93
Debt/EBITDA 6.27
Cap/Depr 31.54%
Cap/Sales 2.6%
Interest Coverage 0.91
Cash Conversion 108.88%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.68
Altman-Z 1.04
F-Score4
WACC4.83%
ROIC/WACC0.47
Cap/Depr(3y)38.37%
Cap/Depr(5y)42.77%
Cap/Sales(3y)3.25%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.7%
Revenue growth 3Y6.82%
Revenue growth 5Y6.95%
Sales Q2Q%3.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30%
EBIT growth 3Y31.87%
EBIT growth 5Y27.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.27%
FCF growth 3Y99.96%
FCF growth 5Y-0.36%
OCF growth 1Y14.51%
OCF growth 3Y38.26%
OCF growth 5Y-1%

RAMSAY GENERALE DE SANTE SA / GDS.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RAMSAY GENERALE DE SANTE SA?

ChartMill assigns a fundamental rating of 2 / 10 to GDS.PA.


What is the valuation status for GDS stock?

ChartMill assigns a valuation rating of 2 / 10 to RAMSAY GENERALE DE SANTE SA (GDS.PA). This can be considered as Overvalued.


Can you provide the profitability details for RAMSAY GENERALE DE SANTE SA?

RAMSAY GENERALE DE SANTE SA (GDS.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for GDS stock?

The financial health rating of RAMSAY GENERALE DE SANTE SA (GDS.PA) is 2 / 10.